Trial intelligence / Profile preview

Effect of liraglutide on physical performance in patients with type 2 diabetes

2012-005197-63Phase 4Completed

Sponsor
Ana M. Wägner
Start
Dec 2012
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Ana M. Wägner. Started Dec 2012; status: completed.

02

Drugs

03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2012-005197-63.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005197-63.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call